Drug Group 6

Antipyretic, non-narcotic analgesic

Produces analgesia by blocking generation of painimpulses probably by inhibition of prostaglandinsynthesis. It relieves fever by central action in thehypothalamic heat regulating center

Fever

None

• Adult: 650-1000 mg PO,
• Pediatric: 10-20 mg / kg

Antihistamine

Antagonizes central and peripheral H1 receptors(nonselective antihistamine); possesses anticholinergicproperties, resulting in antidyskinetic, antiemetic andsedative effects

Allergic and anaphylactic reactions. Dystonicreactions/extrapyramidal symptoms (from phenothiazines,thioxanthines, and butyrophenones)

None in acute prehospital use

• Adult: 25–50 mg IV, IM, or PO
• Pediatric: 1 mg/kg up to adult dose

Hormone

Promotes storage of glucose as glycogen, increasesprotein and fat synthesis, and inhibits the breakdown ofglycogen, protein, and fat. All types of insulin have thesame effect in the body. The differences lie in the onset,duration, concentration, source, and purity. Alsostimulates cellular uptake of potassium.

Hyperkalemia (Most systems do not carry insulin. If allowed byprotocols and available, use the patient’s own insulin. If patient’sCBG is <400, administer D50 to prevent hypoglycemia.)

Hypoglycemia

5-10 units (Regular) IV given with 25 g D50